For much of its clinical history, ketamine treatment required access to a specialized infusion clinic or psychiatry practice, often in a major metropolitan area, with significant out-of-pocket cost, and without meaningful connection to the rest of a patient’s mental health care. Access was, in a word, limited.
The expansion of telehealth, accelerated dramatically by regulatory changes during and after the public health emergency, has begun to change that picture. Virtual mental health care is now mainstream: Trilliant Health documented 66.4 million behavioral health visits in 2024, surpassing the number of primary care visits. Within this broader telehealth expansion, access to ketamine-connected care has evolved meaningfully. This blog explores how telehealth is changing access to ketamine therapy, what that means for patients, and what to look for when evaluating whether a program is clinically credible.
The Historical Access Problem
Prior to the telehealth expansion, accessing ketamine treatment required patients to identify a specialized clinic, often hours away from where they lived, schedule a series of in-person visits, and navigate costs that insurance rarely covered. For people in rural or underserved areas, this was not merely inconvenient; it was practically prohibitive. Someone living outside a major metropolitan area with treatment-resistant depression and limited financial resources had little practical access to a treatment with meaningful evidence behind it.
This access problem exists within a broader mental health care shortage. The Health Resources and Services Administration has documented significant shortages of mental health professionals in large portions of the United States, and wait times for psychiatric care can stretch to months in many areas. People with TRD or complex trauma histories need timely, high-quality care, and the system has often been poorly positioned to provide it.
How Telehealth Has Changed the Picture
The regulatory changes that expanded telehealth prescribing during the COVID-19 public health emergency, including DEA telemedicine flexibilities that allowed controlled substance prescribing via telehealth under certain conditions, opened new pathways for patients to access ketamine-connected care. While the regulatory landscape has continued to evolve, the broader expansion of telehealth mental health care has made the initial clinical evaluation, ongoing psychiatric support, and integration therapy components of ketamine treatment accessible in ways that were not previously possible.
A 2022 study by Hull and colleagues published in the Journal of Affective Disorders examined outcomes in 1,247 patients receiving at-home sublingual ketamine through a telehealth-connected program, and found that 62.8 percent of patients experienced a clinically significant response (a 50 percent or greater reduction in depressive symptoms) at four weeks, results consistent with in-person clinic outcomes. This was an important early signal that telehealth-connected ketamine care could achieve outcomes comparable to traditional models for appropriately selected patients.
What a Telehealth Ketamine Evaluation Looks Like
A telehealth evaluation for ketamine therapy involves the same core clinical components as an in-person evaluation: a comprehensive review of your psychiatric and medical history, current symptoms, prior treatment experience, medication history, and goals for care. The difference is that this evaluation takes place via secure video visit rather than in person, making it substantially more accessible for people who face geographic, logistical, or time-related barriers.
At Vantage Telehealth, the evaluation process begins with a brief intake form that helps your provider understand your history before your first appointment. From there, a licensed clinician conducts a thorough clinical evaluation to determine whether ketamine therapy is appropriate for you. This evaluation is not a rubber stamp; it is a genuine clinical process that determines appropriateness on an individual basis and ensures that any treatment you receive is clinically indicated and safely overseen.
What to Look for in a Ketamine Telehealth Program
The expansion of telehealth ketamine access has been largely positive for patients, but it has also created a landscape where program quality varies significantly. When evaluating any ketamine therapy program, there are several markers of clinical credibility worth considering.
First, the evaluation process should be thorough. Programs that offer minimal clinical screening before approving patients for treatment are concerning from both a safety and efficacy standpoint. A credible program will want to understand your complete clinical picture before recommending ketamine. Second, integration support should be a genuine component of care, not an afterthought. Third, the program should be transparent about what the treatment involves, what outcomes are realistic to expect, and what the follow-up care looks like. Finally, ongoing clinical oversight, not just a single evaluation visit, should be part of the care model.
Psychiatric News and other clinical publications have cautioned about the proliferation of ketamine clinics that provide inadequate clinical oversight, minimal integration support, and aggressive marketing of outcomes. The field’s credibility depends on providers holding to high clinical standards, and patients deserve to know what those standards look like so they can make informed choices.
The Promise of Connected Care
Perhaps the most meaningful advantage of telehealth-connected ketamine care is not simply access to the treatment itself, but access to a more connected model of care. When ketamine therapy is provided as part of a broader virtual mental health practice, it can be integrated with psychotherapy, medication management, lifestyle support, and ongoing psychiatric follow-up in ways that fragmented clinic-only models cannot easily achieve.
This connected care model is what Vantage Telehealth is built around. We are not a ketamine clinic that also does other things; we are a comprehensive telehealth practice that includes ketamine therapy as one evidence-informed option within a full spectrum of mental health care. For patients who qualify, that means ketamine treatment does not exist in isolation. It is part of a relationship with providers who know your history, care about your long-term wellbeing, and are there for the whole arc of your care.
Taking the First Step
If you have been living with depression, PTSD, or another condition that has been difficult to treat, and you have wondered whether ketamine therapy might be worth exploring, Vantage Telehealth makes that conversation straightforward. Our intake process begins online, our providers are licensed and clinically experienced, and our approach to ketamine care is grounded in both the evidence and a genuine commitment to doing this right. Reach out whenever you are ready. We will meet you where you are.
Learn more about ketamine-assisted therapy at Vantage
Frequently Asked Questions
How does telehealth ketamine therapy work?
Telehealth ketamine therapy begins with a video-based clinical evaluation with a licensed provider who reviews your medical and mental health history. If appropriate, oral or sublingual ketamine is prescribed and shipped from a regulated U.S. pharmacy. Sessions are conducted at home with virtual clinical support and structured integration follow-up.
Is telehealth ketamine therapy safe?
When delivered by licensed providers with proper screening, medical history review, and structured protocols, at-home telehealth ketamine has a strong safety record. Vantage requires a support person, a safe setting, and follow-up integration sessions. It is not appropriate for everyone — provider evaluation determines fit.
Who qualifies for telehealth ketamine treatment?
Adults with treatment-resistant depression, PTSD, or another qualifying diagnosis who are medically stable and free of contraindications may qualify. Providers in our partner medical network screen for cardiovascular conditions, active psychosis, substance use concerns, and other factors during evaluation. Not everyone is a candidate — that is by design.
Can you get ketamine prescribed online?
Yes — in Vantage’s model, a licensed provider evaluates you via a secure video visit and, if clinically appropriate, prescribes ketamine that ships from a regulated U.S. pharmacy. This is different from an unregulated online source and includes ongoing clinical follow-up. Provider evaluation is always required.
What conditions can telehealth ketamine treat?
Telehealth ketamine is most commonly used for treatment-resistant depression, PTSD, and severe anxiety when standard treatments have not fully worked. Coverage depends on clinical evaluation and state laws. Providers in our partner medical network review each case individually.
How much does telehealth ketamine cost?
Cash-pay pricing for telehealth ketamine programs typically ranges from a few hundred dollars per month, depending on session frequency and protocol. Vantage publishes transparent pricing so you know what you are paying before you commit. Insurance may cover Spravato but generally not compounded oral ketamine. Compounded ketamine is not FDA-approved for any mental health condition.
See how Vantage Telehealth can help — Get Started →
Disclaimer: This content is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment recommendation. Ketamine is a Schedule III controlled substance and its use for mental health conditions must be supervised by a qualified medical provider. Clinical appropriateness for ketamine therapy is determined on an individual basis by your provider. If you are experiencing a mental health crisis or thoughts of suicide, please call or text 988 (Suicide and Crisis Lifeline), call 911, or go to your nearest emergency room. The information presented here reflects general educational content and may not apply to your specific situation. Always consult a licensed healthcare professional before starting any new treatment.